The Invisalign Palatal Expander (IPE) – American reinvention of the expansion plate or genuine clinical advantage?
Introduction: Transverse maxillary expansion is a cornerstone of early orthodontic treatment. The Invisalign Palatal Expander (IPE) is a digital, sequential system that challenges the traditional expansion plate or rapid palatal expander. In this presentation, we discuss whether this novel system merely represents an evolution or could fundamentally transform digital orthodontic treatment.
System design and handling: The IPE is based on a highly cross-linked polymer resin palatal plate that is, for the first time, directly additively manufactured in series. Following a passive clinical adaptation phase (Stage 0), active expansion of up to 0.25 mm per stage is performed. The standard protocol involves changing the appliance daily or every few days. Digital planning enables a precise control of the expansion stages and allows integration into a fully digital workflow.
Clinical results and target groups: The primary patient group comprises children in the first and second mixed dentition phases. The system is well accepted in this group because of its greater comfort and improved hygiene compared with fixed appliances (e.g. Quad Helix). The use in older patients is also critically examined: Where are the limits of dental expansion without skeletal anchorage, and which clinical effects can still be achieved?
Discussion and evaluation: Based on clinical case examples, the advantages and disadvantages are weighed against conventional alternatives (expansion plate, rapid palatal expansion). Particular attention is paid to the challenges of patient compliance and the predictability of outcomes.
Summary: As part of digitally based early orthodontic treatment, the IPE may offer advantages in terms of precision and handling. With regard to future directly additively manufactured orthodontic polymer appliances, it could become more than a “modern expansion plate” and already functions as a digitally manufactured tool for controlled transverse development. However, its limits of application, particularly in older patients, must still be clearly defined.
